Stewart Capital, LLC

About The Fund

Stewart Capital, LLC, operating as Longwood Fund, is a venture capital firm based in The Prudential Tower, Boston, Massachusetts, with a specialty in the life sciences sector. The firm is focused on creating and investing in companies that develop innovative solutions for significant medical problems. With an emphasis on partnership with world-class scientific co-founders, Longwood Fund identifies groundbreaking discoveries, particularly those that have the potential to greatly improve patient lives. They have a hands-on approach, often taking on roles such as Co-Founding CEO, CBO, or President, to actively build and steer the companies they invest in. As a value-add investor, Longwood supports its portfolio companies throughout the journey from lab to patient, helping to accelerate the translation of scientific discoveries into therapeutics. The firm is known for hosting semi-annual industry meetings that convene thought leaders and decision-makers from government, pharma, biotech, and academia to foster collaboration and innovation. At these meetings, advancements, collaborations and access to innovation are discussed to push the development of new medicines. Longwood's portfolio boasts an impressive track record, with a $170 billion sustained market/exit value of companies co-founded by the fund's partners, 20+ therapies and products have been brought to market, 35+ assets are in the clinic undergoing research, and 25 companies have been co-founded by Longwood's partners. Longwood Fund has been instrumental in creating thousands of jobs in the Boston area and enjoys a strong reputation among industry leaders. The fund specializes in Seed, Startup, and Early Stage investments, bringing financial resources, expertise in equity, and strategic support to the companies they empower. With assets under management amounting to $85 million, Longwood Fund remains a pivotal player in the biotech ecosystem in Boston and beyond.